1. Divis Laboratories
Divis Laboratories Share Price

Divis Laboratories Share Price

NSE: DIVISLAB | BSE: 532488 | Pharmaceuticals

43% Sell

₹6,557.00

+₹104.50 (1.62%) Last updated on 21 May, 2025 | 13:01 IST

Divis Laboratories Overview

Market cap
Market Cap Switch₹1,71,294 Crs
Open
₹6,454.00
Prev. Close
₹6,452.50
Circuit range
₹7,097.50 - ₹5,807.50
Day range
₹6,454.00 - ₹6,596.50
Year range
₹3,850.00 - ₹6,705.00
Volume
4,04,843
Avg. traded
₹6,556.66
Revenue (12m)
₹9,311 Crs

About Divis Laboratories

Divi’s Laboratories Ltd is a Hyderabad-based pharmaceutical company. It is a leading manufacturer of active pharmaceutical ingredients (APIs) and supplies its products to more than 100 countries. The company which is counted among the top API manufacturers in the world has been operating for the last 30 years.

Divi’s started as Divi’s Research Centre (DRC) in 1990. It set up its first manufacturing unit in Hyderabad in 1995 and received the USFDA inspection for the first time in 2000. The company set up its second manufacturing unit near Vishakhapatnam in 2002 and a year later was listed on BSE and NSE.

The company entered into the nutraceuticals segment in 2007. It also set up a new research unit in Hyderabad in 2010.

At present, Divi’s Laboratories has 16,500 trained professionals across departments and around 400 scientists working at its three research centres. It has two manufacturing facilities at Vizag and Hyderabad.

Business highlights

Divi’s Lab has a market valuation of Rs 98,600 crore as of December 19, 2023. Divi’s Lab shares price has dropped nearly 3% in three years.

The company’s business operations span across research and development activities and manufacturing operations. Its two main manufacturing facilities in Vizag and Hyderabad produce thousands of tonnes of APIs that are exported to around 100 countries.

Divi’s Laboratories have three main business segments:

Generic APIs

Divi’s Laboratories offers 30 generic active pharmaceutical ingredients to customers across the world. Its operations are bolstered by backward integration to basic starting materials, devoted production blocks with large batch sizes and significant capacity creation.

The company is a global leader in large-volume generic APIs. It looks to achieve global leadership in molecules and around 10 APIs are in the research and development stage. Its manufacturing plants have been audited by various regulatory authorities, as well as global environmental, health and safety teams.

Customs Synthesis

Divi’s Laboratories is involved in contract manufacturing services (custom synthesis) of APIs and intermediates for global companies. It has a portfolio of products across diverse therapeutic areas. The company has 12 out of the top 20 big pharma companies across US, Europe and Japan as its customers for more than 10 years.

Divi’s being a core generic API manufacturer has a research and development (R&D) team of more than 400 scientists.

Nutraceutical

The nutraceutical plant of Divi’s Laboratories is an integrated facility for the production of API and finished forms of Carotenoids. The company supplies carotenoids to major food, dietary supplement and feed manufacturers around the world.

Financial Highlights

Divi's Laboratories consolidated total income was ₹8,112 crore for FY23 against ₹9074 crore in FY22, a fall of 11% year-on-year. Total expenses were ₹ 5,620 crore in FY23 against ₹ 5315 crore in FY22. Divi's reported profit before tax of ₹2,369 crore for FY23 against ₹ 3,684 crore for the previous year. Profit after tax in FY23 was ₹1,823 crore against ₹2,960 crore in FY22.

  • Chart
  • Fundamentals
  • Financials
  • F&O
  • Shareholdings
  • Events
  • Peers
  • News
  • FAQs

Divis Laboratories Share Price Chart

Please wait...

Divis Laboratories Key Indicators

P/E ratio
78
P/B ratio
11.38
ROE
12.04%
ROCE
16.31%
Dividend yield
0.5%
Debt/Equity ratio
EPS
59.47

Investment Checklist: (3/6)

passed

Equity returns

not passed

Dividend returns

passed

Safety factor

NA

Growth factor

passed

Debt vs Equity

NA

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst Ratings:

Sell

Buy

35%

Hold

22%

Sell

43%

This analysis is based on the reviews of 23 experts in the last 7 days

Divis Laboratories Financial Ratios

  • Profitability

  • Operational

  • Valuation

Operating profit margin

32.58%

Net profit margin

20.44%

ROE

12.04%

ROA

10.29%

ROCE

16.31%

Divis Laboratories Shareholder returns

1 day
-1.94%
1 week
+6.19%
1 month
+14.41%
3 months
+7.93%
1 year
+64.23%
3 years
+49.89%
5 years
+171.95%

Revenue Statement

All values are in ₹ Crores (Cr)
RevenueNo Sort
Operating ProfitNo Sort
Net ProfitNo Sort
Mar-24
7,845.00
2,545.00
1,600.00
Mar-23
7,767.00
2,714.00
1,824.00
Mar-22
8,959.83
3,997.01
2,960.45
Mar-21
6,969.40
2,923.73
1,984.29

Cash Flow

All values are in ₹ Crores (Cr)
OperatingNo Sort
InvestingNo Sort
FinancingNo Sort
Mar-24
1,261.00
-269
-799.00
Mar-23
2,459.00
-2,707
-797.00
Mar-22
1,911.80
-2,194.92
-532.44
Mar-21
1,946.93
75.13
-34.89

Balance Sheet

All values are in ₹ Crores (Cr)
Total AssetNo Sort
Total LiabilityNo Sort
Mar-24
15,937.00
2,366.00
Mar-23
14,863.00
2,096.00
Mar-22
14,619.13
2,890.95
Mar-21
11,386.90
2,092.29

Divis Laboratories Share Price History

DayOpenCloseChange %
20-May-25
₹6,580.00
₹6,452.50
-1.94%
19-May-25
₹6,400.00
₹6,580.00
+4.79%
16-May-25
₹6,239.00
₹6,279.50
+1.05%
15-May-25
₹6,198.50
₹6,214.50
-0.02%
14-May-25
₹6,100.00
₹6,215.50
+2.29%
13-May-25
₹5,955.50
₹6,076.50
+2.26%
12-May-25
₹6,035.00
₹5,942.00
-1.39%
09-May-25
₹5,841.50
₹6,025.50
+1.09%

Divis Laboratories Shareholding Pattern

Promoters (51.89%)

Mutual Funds (12.83%)

Retail and other (9.39%)

Foreign institutions-FII (18.01%)

Other domestic institutions (7.88%)

Promoters

Corporate Actions

  • Dividend • ₹30/share

    Ex date 02 Aug 2024

    expand tab
  • Dividend • ₹30/share

    Ex date 11 Aug 2023

    expand tab

Stocks Similar to Divis Laboratories

PriceNo Sort
Change %No Sort
Alkem Laboratories₹5,323.00+₹64.00 (1.22%)
Aurobindo Pharma₹1,205.00+₹13.20 (1.11%)
Biocon₹339.20+₹6.70 (2.02%)
Cipla₹1,487.20+₹32.80 (2.26%)
Gland Pharma₹1,568.00+₹69.70 (4.65%)
Piramal Enterprises₹1,137.45+₹29.75 (2.69%)
Sun Pharmaceutical Industries₹1,739.00+₹31.20 (1.83%)
Torrent Pharmaceuticals₹3,292.10+₹50.60 (1.56%)
Zydus Lifesciences₹894.20+₹10.90 (1.23%)

Popular Stocks

PriceNo Sort
Change %No Sort
Asian Paints₹2,307.00+₹11.40 (0.50%)
Bajaj Finance₹9,187.00+₹108.00 (1.19%)
HDFC Bank₹1,926.30+₹11.40 (0.60%)
Infosys₹1,566.20+₹5.60 (0.36%)
ITC₹434.40-₹0.50 (-0.11%)
JIO FIN SERVICES LTD₹273.25+₹1.80 (0.66%)
Reliance₹1,425.50+₹0.90 (0.06%)
Tata Motors₹722.75+₹3.85 (0.54%)
Tata Power₹398.95+0.00 (0.00%)
TCS₹3,525.20+₹26.90 (0.77%)

FAQs on Divis Laboratories

What is the share price of Divis Laboratories today?

chevron-up
Divis Laboratories share price is ₹ 6,557.00 as on 21 May, 2025 | 13:01 IST.

What are the high & low stock price of Divis Laboratories today?

chevron-up
Divis Laboratories stock price hit a high of ₹ 6,596.50 and low of ₹ 6,454.00 as on 21 May, 2025 | 13:01 IST.

What is the market cap of Divis Laboratories?

chevron-up
The market cap of Divis Laboratories is ₹ 1,71,293.60 Crores as on 21 May, 2025 | 13:01 IST.

What are the the 52-week high and low share prices of Divis Laboratories stock on the NSE?

chevron-up
52-week high stock Price of Divis Laboratories is ₹ 6,705.00 and Low Price is ₹ 3,850.00 as on 21 May, 2025 | 13:01 IST.

What are the stock symbols of Divis Laboratories?

chevron-up
The stock symbol of Divis Laboratories is NSE: DIVISLAB on the NSE and BSE: 532488 on the BSE, and the ISIN is INE361B01024.

Can I buy Divis Laboratories shares on Holidays?

chevron-up
No, shares of Divis Laboratories or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Divis Laboratories shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.

What is the PE and PB ratio of Divis Laboratories?

chevron-up
The PE and PB ratio of Divis Laboratories is 78 and 11.38 respectively, as on 21 May, 2025 | 13:01 IST.

What are the returns on Divis Laboratories shares?

chevron-up
The historical returns for Divis Laboratories shares are 64.23 for 1 year, 49.89 for 3 year and 171.95 for 5 year.